Help Us Protect Access to Sexual and Reproductive Health Care Today!
Feb 14
Since EC isn’t available over-the-counter to everyone yet, clinicians should be well-versed in the different types of emergency contraception. This Contraceptive Pearl details the different types so clinicians can know what will work best for their patients.
Jan 01
The progestin implant, Implanon, introduced in 1999, has been replaced by an updated version called Nexplanon. The Contraceptive Pearl covers the differences between Implanon and Nexplanon.
Dec 01
Contraception is especially important for HIV+ women due to the risks that pregnancy can bring on. Different types of contraception and how they work for HIV+ women are detailed in this Contraceptive Pearl.
Dec 01
A 2011 policy resolution calling for state academy endorsement of the One Key Question, which requires doctors to routinely asses a person’s pregnancy intentions and to provide appropriate services as indicated.
Dec 01
A 2011 policy resolution calling for federal agencies to take action to ensure that community health centers provide access to all contraceptive methods.
Dec 01
A 2011 policy resolution calling for AAFP endorsement of the United States Medical Eligibility Criteria for Contraceptive Use.
Dec 01
A 2011 policy resolution calling for Crisis Pregnancy Centers to disclose that the center is not a medical facility, that it does not perform or provide referrals for abortion or contraception, and that it is not bound by HIPAA requirements protecting confidentiality.
Nov 01
Several researchers have tried to find a counseling approach that leads women to stick with their contraceptive method longer. So far, the results are disappointing! This Contraceptive Pearl discusses why adherence is low and what clinicians can do about it.
Oct 10
This Contraceptive Pearl covers the best practice to confidentially discuss and prescribe contraception with teens.
Sep 01
Studies of the contraceptive patch and Deep Vein Thrombosis (DVT) have yielded conflicting results. In 2006, two trials found a higher incidence of nonfatal blood clots among women using the patch than among women taking oral contraceptives, while a third study found no significant difference. How can we frame this discussion so that we communicate honestly without alarming patients?